BRUNO, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 211
AS - Asia 189
NA - Nord America 182
SA - Sud America 2
Totale 584
Nazione #
US - Stati Uniti d'America 171
SG - Singapore 113
DE - Germania 109
HK - Hong Kong 72
IT - Italia 68
CA - Canada 11
RU - Federazione Russa 8
EE - Estonia 6
FI - Finlandia 5
GB - Regno Unito 4
BD - Bangladesh 3
NL - Olanda 3
BE - Belgio 2
BR - Brasile 2
ES - Italia 2
AT - Austria 1
CH - Svizzera 1
LT - Lituania 1
SE - Svezia 1
TR - Turchia 1
Totale 584
Città #
Hong Kong 72
Falkenstein 60
Singapore 52
Frankfurt am Main 40
Rome 33
West Jordan 32
Chicago 30
Boardman 21
Moscow 8
Naples 6
Toronto 6
Buffalo 5
Charlotte 5
Helsinki 5
Ottawa 5
Ashburn 4
Bologna 4
Los Angeles 4
Sant'Elpidio a Mare 4
The Dalles 4
Ettlingen 3
Galbiate 3
New York 3
Brussels 2
Diano d'Alba 2
London 2
San Francisco 2
Seattle 2
São Paulo 2
Turin 2
Zona Industriale 2
Amsterdam 1
Arosio 1
Atlanta 1
Brooklyn 1
Dallas 1
Grellingen 1
Secaucus 1
Stockholm 1
Totale 433
Nome #
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 26
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 26
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 25
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 25
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 25
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 25
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 25
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 24
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 24
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 24
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 24
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 24
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 23
Osteopontin Is Associated with Multiple Sclerosis Relapses 23
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 23
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 23
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 21
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 18
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 18
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 18
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 18
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 18
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 17
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 17
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 16
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 16
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 15
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 15
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 15
Totale 636
Categoria #
all - tutte 5.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202499 0 0 0 0 0 0 24 0 0 64 2 9
2024/2025537 15 37 7 38 53 33 115 111 30 15 74 9
Totale 636